| Identification | More | [Name]
Fmoc-Met-OH | [CAS]
112883-40-6 | [Synonyms]
9-FLUORENYLMETHOXYCARBONYL-D-METHIONINE
FMOC-D-MET
FMOC-D-METHIONINE
FMOC-D-MET-OH
N-(9-FLUORENYLMETHOXYCARBONYL)-D-METHIONINE
N-9-FLUORENYLMETHYLOXYCARBONYL-D-METHIONINE
N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-D-METHIONINE
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-METHIONINE
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-D-METHIONINE
N-ALPHA-FMOC-D-METHIONINE
N-FMOC-D-METHIONINE
FMOC-D-METHIONINE 98+%
N-ALPHA-9-FLUORENYLMETHOXYCARBONYL-D-METHIONINE(FMOC-D-MET-OH)
Fmoc-Met-OH
FMOC-D-METHIONINE extrapure
9-fluorenylmethyloxycarbonyl-D-methionine-OH | [EINECS(EC#)]
276-258-5 | [Molecular Formula]
C20H21NO4S | [MDL Number]
MFCD00062958 | [Molecular Weight]
371.45 | [MOL File]
112883-40-6.mol |
| Chemical Properties | Back Directory | [Melting point ]
132 °C | [Boiling point ]
614.6±55.0 °C(Predicted) | [density ]
1.282±0.06 g/cm3(Predicted) | [refractive index ]
30 ° (C=1, DMF) | [storage temp. ]
2-8°C
| [solubility ]
Chloroform (Slightly), DMF (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
3.72±0.10(Predicted) | [color ]
White to Off-White | [BRN ]
5384578 | [Major Application]
peptide synthesis | [InChI]
1S/C20H21NO4S/c1-26-11-10-18(19(22)23)21-20(24)25-12-17-15-8-4-2-6-13(15)14-7-3-5-9-16(14)17/h2-9,17-18H,10-12H2,1H3,(H,21,24)(H,22,23)/t18-/m1/s1 | [InChIKey]
BUBGAUHBELNDEW-GOSISDBHSA-N | [SMILES]
CSCC[C@@H](NC(=O)OCC1c2ccccc2-c3ccccc13)C(O)=O | [CAS DataBase Reference]
112883-40-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Safety Statements ]
S22:Do not breathe dust .
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [HS Code ]
29309090 | [Storage Class]
11 - Combustible Solids |
| Hazard Information | Back Directory | [Chemical Properties]
Light yellow solid | [Uses]
N-Fmoc-D-methionine is an N-Fmoc-protected form of D-Methionine (M260550). D-Methionine is an isomer of L-Methionine (M260440), and is known to be a cytoprotectant against Cisplatin (C499500), an anticancer agent. D-Methionine is also used to prevent noise- and drug-induced hearing loss, as well as hair loss (all of which may also be caused by Cisplatin or aminoglycosides). | [reaction suitability]
reaction type: Fmoc solid-phase peptide synthesis |
|
|